These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16918826)

  • 1. Randomized trials are also essential for device therapy.
    Rück A; Sylvén C
    J Intern Med; 2006 Sep; 260(3):281; author reply 282-3. PubMed ID: 16918826
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enhanced external counterpulsation. Evidence of effect on patients suffering from angina pectoris and for whom revascularisation is not possible].
    May O
    Ugeskr Laeger; 2007 Jun; 169(26):2507-12. PubMed ID: 17725894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External counterpulsation for treatment of chronic stable angina pectoris and chronic heart failure.
    Technol Eval Cent Assess Program Exec Summ; 2005 Dec; 20(12):1-3. PubMed ID: 16489723
    [No Abstract]   [Full Text] [Related]  

  • 4. [EECP--new treatment in refractory angina. Clinical trials show good results].
    Yu W; Pettersson T; Ohlsson O; Bondesson S; Edvinsson L; Johnsson P
    Lakartidningen; 2006 Jun 14-27; 103(24-25):1930, 1933-4. PubMed ID: 16838577
    [No Abstract]   [Full Text] [Related]  

  • 5. [There is a crunch in assessment of non-pharmacological therapy. Controlled trials necessary in refractory angina pectoris].
    Rück A; Sylvén C
    Lakartidningen; 2006 Jun 14-27; 103(24-25):1918-9. PubMed ID: 16838575
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced external counterpulsation: a new modality in the treatment of angina and heart failure.
    Arora RR; Shah AG
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):271-3. PubMed ID: 17220474
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: One year perspective on COURAGE.
    Sedlis SP; Boden WE; Weintraub WS; Maron DS; O'Rourke RA; Berman DS; Mancini GB;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):428. PubMed ID: 19133682
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced external counterpulsation for the treatment of angina pectoris.
    Cohn PF
    Prog Cardiovasc Dis; 2006; 49(2):88-97. PubMed ID: 17046434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of chronic stable angina pectoris.
    Rodríguez-Ospina L; Montano-Soto L
    Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the real (non-intent to treat--isolated sole therapy) 5-year results of Ho:YAG TMR therapy?
    Furnary AP
    Ann Thorac Surg; 2005 Jun; 79(6):2200; author reply 2200-1. PubMed ID: 15919356
    [No Abstract]   [Full Text] [Related]  

  • 11. Primer: practical approach to the selection of patients for and application of EECP.
    Michaels AD; McCullough PA; Soran OZ; Lawson WE; Barsness GW; Henry TD; Linnemeier G; Ochoa A; Kelsey SF; Kennard ED
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):623-32. PubMed ID: 17063167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More on low-fat diets.
    Thompson PD
    N Engl J Med; 1998 May; 338(22):1623-4. PubMed ID: 9606119
    [No Abstract]   [Full Text] [Related]  

  • 13. COURAGE to make choices. When it comes to treating angina or a narrowed coronary artery, angioplasty is no better than medical therapy for preventing heart attacks or premature death.
    Harv Heart Lett; 2007 Jun; 17(10):5. PubMed ID: 17654799
    [No Abstract]   [Full Text] [Related]  

  • 14. [COURAGE Study shows: angina pectoris despite optimal therapy. Nonetheless, every 4th patient suffers despite drugs and PCI from angina pectoris attacks].
    Gerdts KG
    MMW Fortschr Med; 2008 Jun; 150(26-27):28-9. PubMed ID: 18681227
    [No Abstract]   [Full Text] [Related]  

  • 15. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evident placebo effect in refractory angina pectoris. Do refer to the placebo-controlled study at the Huddinge hospital!].
    Rück A; Drvota V; Sylvén C
    Lakartidningen; 2001 Dec; 98(50):5794-5. PubMed ID: 11789107
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure.
    Manchanda A; Soran O
    J Am Coll Cardiol; 2007 Oct; 50(16):1523-31. PubMed ID: 17936150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of patients undergoing enhanced external counterpulsation and spinal cord stimulation for refractory angina pectoris.
    Bondesson S; Pettersson T; Erdling A; Hallberg IR; Wackenfors A; Edvinsson L
    Coron Artery Dis; 2008 Dec; 19(8):627-34. PubMed ID: 19005298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced external counterpulsation: an innovative physical therapy for refractory angina.
    Braverman DL
    PM R; 2009 Mar; 1(3):268-76. PubMed ID: 19627906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the efficacy and safety of enhanced external counterpulsation at West Virginia University Hospitals.
    Sajja V; Dod H; Beto R; Jain AC; Hobbs GR; Finkel MS
    W V Med J; 2007; 103(3):10-2. PubMed ID: 17849668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.